Sarcoidosis Treatment with Antifungal Medication: A Follow-Up

Table 1

Characteristics of subjects in different groups at initiation of treatment. Number () or arithmetic mean/SEM.

Treatment	Corticosteroid	Antifungal	AF + C
	21	20	27
Age years	44.0/3.4	42.4/2.3	41.1/2.0
Smokers	3	1	4
Females	10	9	12
Stage 2	19	20	21
Stage 3	2	0	6
Extrapulmonary	12	8	9
CD4/CD8	6.9/0.9	6.4/0.9	6.5/0.8
VC %	89.3/2.9	97.3/1.0	93.7/1.9
FEV1 %	89.1/3.0	94.3/2.3	92.5/2.3
DLco %	80.5/3.6	92.3/3.3	89.6/3.5